SG Americas Securities LLC Boosts Stock Position in Centene Corporation $CNC

SG Americas Securities LLC raised its stake in Centene Corporation (NYSE:CNCFree Report) by 375.0% during the 4th quarter, HoldingsChannel reports. The firm owned 802,206 shares of the company’s stock after acquiring an additional 633,335 shares during the period. SG Americas Securities LLC’s holdings in Centene were worth $33,011,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also modified their holdings of the stock. Addison Advisors LLC lifted its holdings in shares of Centene by 455.6% during the third quarter. Addison Advisors LLC now owns 739 shares of the company’s stock worth $26,000 after purchasing an additional 606 shares during the period. Mowery & Schoenfeld Wealth Management LLC acquired a new position in Centene in the 3rd quarter valued at $27,000. GoalVest Advisory LLC purchased a new position in Centene during the 4th quarter worth $37,000. Union Bancaire Privee UBP SA acquired a new stake in shares of Centene in the 4th quarter worth $37,000. Finally, WPG Advisers LLC boosted its holdings in shares of Centene by 44.5% in the third quarter. WPG Advisers LLC now owns 915 shares of the company’s stock valued at $33,000 after acquiring an additional 282 shares in the last quarter. Hedge funds and other institutional investors own 93.63% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on CNC. Robert W. Baird increased their price target on shares of Centene from $28.00 to $36.00 and gave the stock a “neutral” rating in a report on Thursday, December 11th. Truist Financial boosted their target price on Centene from $47.00 to $49.00 and gave the stock a “buy” rating in a research report on Wednesday, February 25th. Wall Street Zen downgraded Centene from a “buy” rating to a “hold” rating in a research note on Sunday, February 15th. JPMorgan Chase & Co. decreased their price target on Centene from $45.00 to $41.00 and set a “neutral” rating on the stock in a research note on Thursday, March 19th. Finally, Weiss Ratings reiterated a “sell (d)” rating on shares of Centene in a research report on Wednesday, January 21st. Three equities research analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and three have given a Sell rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $41.81.

View Our Latest Research Report on CNC

Centene Price Performance

CNC stock opened at $32.61 on Thursday. The firm has a 50 day moving average of $40.94 and a 200-day moving average of $38.69. The company has a market cap of $16.03 billion, a price-to-earnings ratio of -2.39, a PEG ratio of 0.73 and a beta of 0.48. The company has a current ratio of 1.10, a quick ratio of 1.10 and a debt-to-equity ratio of 0.87. Centene Corporation has a 12-month low of $25.08 and a 12-month high of $66.03.

Centene (NYSE:CNCGet Free Report) last released its quarterly earnings results on Friday, February 6th. The company reported ($1.19) earnings per share for the quarter, topping analysts’ consensus estimates of ($1.22) by $0.03. The business had revenue of $49.73 billion for the quarter, compared to analysts’ expectations of $48.41 billion. Centene had a positive return on equity of 4.25% and a negative net margin of 3.43%.The company’s revenue was up 21.9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.80 EPS. Centene has set its FY 2026 guidance at 3.000-3.000 EPS. As a group, equities analysts expect that Centene Corporation will post 6.86 EPS for the current fiscal year.

Centene Profile

(Free Report)

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.

Read More

Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Corporation (NYSE:CNCFree Report).

Institutional Ownership by Quarter for Centene (NYSE:CNC)

Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.